Literature DB >> 32827583

The emerging role of miRNA clusters in breast cancer progression.

Amoolya Kandettu1, Raghu Radhakrishnan2, Sanjiban Chakrabarty3, S Sriharikrishnaa1, Shama Prasada Kabekkodu4.   

Abstract

Micro RNAs (miRNAs) are small non-coding RNAs that are essential for regulation of gene expression of the target genes. Large number of miRNAs are organized into defined units known as miRNA clusters (MCs). The MCs consist of two or more than two miRNA encoding genes driven by a single promoter, transcribed together in the same orientation, that are not separated from each other by a transcription unit. Aberrant miRNA clusters expression is reported in breast cancer (BC), exhibiting both pro-tumorogenic and anti-tumorigenic role. Altered MCs expression facilitates to breast carcinogenesis by promoting the breast cells to acquire the various hallmarks of the cancer. Since miRNA clusters contain multiple miRNA encoding genes, targeting cluster may be more attractive than targeting individual miRNAs. Besides targeting dysregulated miRNA clusters in BC, studies have focused on the mechanism of action, and its contribution to the progression of the BC. The present review provides a comprehensive overview of dysregulated miRNA clusters and its role in the acquisition of cancer hallmarks in BC. More specifically, we have presented the regulation, differential expression, classification, targets, mechanism of action, and signaling pathways of miRNA clusters in BC. Additionally, we have also discussed the potential utility of the miRNA cluster as a diagnostic and prognostic indicator in BC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Diagnosis; Prognosis; Signaling pathways; Therapeutic resistnce; miRNA cluster

Mesh:

Substances:

Year:  2020        PMID: 32827583     DOI: 10.1016/j.bbcan.2020.188413

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  14 in total

1.  Mechanosensitive pathways are regulated by mechanosensitive miRNA clusters in endothelial cells.

Authors:  Sean Herault; Jarka Naser; Daniele Carassiti; K Yean Chooi; Rosa Nikolopoulou; Marti Llopart Font; Miten Patel; Ryan Pedrigi; Rob Krams
Journal:  Biophys Rev       Date:  2021-10-23

Review 2.  Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts.

Authors:  Li-Jie Li; Wei-Min Chang; Michael Hsiao
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

3.  Hsa_circ_0001982 promotes the progression of breast cancer through miR-1287-5p/MUC19 axis under hypoxia.

Authors:  Zhimin Qiu; Ling Wang; Huaidong Liu
Journal:  World J Surg Oncol       Date:  2021-06-03       Impact factor: 2.754

4.  LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c.

Authors:  Ravindra Pramod Deshpande; Sambad Sharma; Yin Liu; Puspa Raj Pandey; Xinhong Pei; Kerui Wu; Shih-Ying Wu; Abhishek Tyagi; Dan Zhao; Yin-Yuan Mo; Kounosuke Watabe
Journal:  Breast Cancer Res       Date:  2022-01-25       Impact factor: 6.466

5.  The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.

Authors:  Yadi Zhou; Zhenghao Zhang; Mingyi Wo; Wenfang Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  miR-1293 acts as a tumor promotor in lung adenocarcinoma via targeting phosphoglucomutase 5.

Authors:  Bing Chen; Shiya Zheng; Feng Jiang
Journal:  PeerJ       Date:  2021-09-16       Impact factor: 2.984

7.  Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression.

Authors:  Boshi Yu; Mengmeng Li; Shu Ping Han; Zhangbin Yu; Jingai Zhu
Journal:  Mol Med Rep       Date:  2021-10-19       Impact factor: 2.952

Review 8.  MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer.

Authors:  Marie-Therese Haider; Daniel J Smit; Hanna Taipaleenmäki
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

9.  MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.

Authors:  Xiaoqiang Zhai; Yan Wu; Dong Zhang; Hecheng Li; Tie Chong; Jun Zhao
Journal:  J Bioenerg Biomembr       Date:  2021-03-08       Impact factor: 2.945

Review 10.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.